InvestorsObserver
×
News Home

Should You Sell Anixa Biosciences Inc (ANIX) in Biotechnology Industry?

Friday, June 17, 2022 11:47 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Sell Anixa Biosciences Inc (ANIX) in Biotechnology Industry?

Anixa Biosciences Inc (ANIX) is near the top in its industry group according to InvestorsObserver. ANIX gets an overall rating of 70. That means it scores higher than 70 percent of stocks. Anixa Biosciences Inc gets a 92 rank in the Biotechnology industry. Biotechnology is number 66 out of 148 industries.

Overall Score - 70
ANIX has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on ANIX!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 70 means the stock is more attractive than 70 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Anixa Biosciences Inc Stock Today?

Anixa Biosciences Inc (ANIX) stock is down -1.61% while the S&P 500 has risen 0.13% as of 11:43 AM on Friday, Jun 17. ANIX has fallen -$0.05 from the previous closing price of $3.20 on volume of 15,285 shares. Over the past year the S&P 500 is lower by -13.04% while ANIX has fallen -23.97%. ANIX lost -$0.52 per share the over the last 12 months. Click Here to get the full Stock Report for Anixa Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App